Loading
Latest filing published 13 Oct 2026 for Imunon, Inc., €2,863.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stacy Lindborg discloses dealings in 2 companies, chiefly Imunon, Inc. and Brainstorm Cell Therapeutics Inc. In total, 18 filings cover trades dated from 1 June 2020 to 9 October 2026.
On the market, this insider has only ever bought: 2 purchases, €41k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 15 share grants and 1 option exercise.
Most recently, on 13 October 2026, the filings show a share grant worth €2,863 in Imunon, Inc. The last insider purchase was made public on 16 August 2024, 799 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations